0000950170-24-071493.txt : 20240610 0000950170-24-071493.hdr.sgml : 20240610 20240610185607 ACCESSION NUMBER: 0000950170-24-071493 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240606 FILED AS OF DATE: 20240610 DATE AS OF CHANGE: 20240610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Walker Karen Marie CENTRAL INDEX KEY: 0002008556 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41947 FILM NUMBER: 241034226 MAIL ADDRESS: STREET 1: C/O KYVERNA THERAPEUTICS, INC. STREET 2: 5980 HORTON ST., SUITE 550 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kyverna Therapeutics, Inc. CENTRAL INDEX KEY: 0001994702 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 831365441 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5980 HORTON STREET STREET 2: SUITE 550 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 5106268331 MAIL ADDRESS: STREET 1: 5980 HORTON STREET STREET 2: SUITE 550 CITY: EMERYVILLE STATE: CA ZIP: 94608 4 1 ownership.xml 4 X0508 4 2024-06-06 0001994702 Kyverna Therapeutics, Inc. KYTX 0002008556 Walker Karen Marie C/O KYVERNA THERAPEUTICS, INC. 5980 HORTON ST., STE 550 EMERYVILLE CA 94608 false true false false Chief Technology Officer false Common Stock 2024-06-06 4 M false 9636 4.42 A 9636 D Stock Option (Right to Buy) 4.42 2024-06-06 4 M false 9636 0 D Common Stock 9636 82648 D 25% of the original number of shares subject to the option vested on September 13, 2022, and 1/48th of the original number of shares subject to the option vested or shall vest in monthly installments thereafter. By: /s/ Karen Walker 2024-06-10